WRW4 TFA

发表于2023年12月28日由Whatman官网

WRW4 TFA;

WRW4 TFA 是一种特异的甲酰肽受体样 1 (FPRL1) 拮抗剂，抑制 WKYMVm 与 FPRL1 的 IC₅₀ 为 0.23 μM。WRW4 TFA 抑制 FPRL1 激动剂 MMK-1、淀粉样 β 42 (Abeta42) 肽和F肽引起的细胞内钙的增加。

WRW4 TFAamp;;

WRW4 TFA Chemical Structure

规格		是否有货
100 mg	;	询价	;
250 mg	;	询价	;
500 mg	;	询价	;

* Please select Quantity before adding items.

生物活性	WRW4 TFA, a specific formyl peptide receptor-like 1 (FPRL1) antagonist, inhibits WKYMVm binding to FPRL1 with an IC₅₀ of 0.23 μM. WRW4 TFA specifically inhibits the increase in intracellular calcium by the FPRL1 agonists MMK-1, amyloid beta42 (Abeta42) peptide, and F peptide^[1].
体外研究 (In Vitro)	WRW4 TFA inhibits Abeta42 peptide-induced superoxide generation and chemotactic migration of neutrophils, and also completely inhibits the internalization of Abeta42 peptide in human macrophages. WRW4 TFA specifically blocks ERK phosphorylation downstream of FPRL1 by WKYMVm^[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
分子量	1218.29
Formula	C₆₃H₆₆F₃N₁₅O₈
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Bae YS, et al. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J Immunol. 2004;173(1):607-614.